Le Lézard
Classified in: Health
Subjects: NPT, LEG, POL, AVO

More Than 235 Organizations Show Their Support for the Improving Care and Access to Nurses Act


WASHINGTON, June 6, 2023 /PRNewswire/ -- Today, the American Association of Nurse Practitioners® (AANP) and more than 235 organizations sent a letter to the leaders of the U.S. House of Representatives Committee on Ways and Means and the Committee on Energy and Commerce illustrating strong support for H.R. 2713, the Improving Care and Access to Nurses (ICAN) Act.

This critical legislation will remove outdated barriers to practice that delay access to health care for our patients

"This critical legislation will remove outdated barriers to practice that delay access to health care for our patients," said AANP President April Kapu, DNP. "Health care policies should be responsive to patient needs and inclusive of the health care providers delivering care in our communities. The ICAN Act will move health care delivery forward for patients, providers and our nation."

This bipartisan legislation, which was introduced in April in the House of Representatives, would authorize nurse practitioners (NPs) to order cardiac and pulmonary rehabilitation, certify when patients with diabetes need therapeutic shoes, ensure NPs' patients are represented in the beneficiary attribution process for the Medicare Shared Savings Program, refer patients for medical nutrition therapy, certify and recertify a patient's terminal illness for hospice eligibility, perform all mandatory examinations in skilled nursing facilities and more.

NPs provide high-quality health care to Medicare and Medicaid patients across all geographic areas and health care settings. Over 40% of Medicare beneficiaries receive care from NPs, and NPs are the fastest-growing Medicare provider group. Yet, despite the high-quality health care NPs provide to Medicare and Medicaid beneficiaries, barriers still exist within the programs that prevent the effective and efficient delivery of care.

AANP is proud that this legislation is supported by such a wide-ranging, comprehensive coalition of national, state and local organizations.  

Read the full letter.

The American Association of Nurse Practitioners® (AANP) is the largest professional membership organization for nurse practitioners (NPs) of all specialties. It represents the interests of the more than 355,000 licensed NPs in the U.S. AANP provides legislative leadership at the local, state and national levels, advancing health policy; promoting excellence in practice, education and research; and establishing standards that best serve NPs' patients and other health care consumers. As The Voice of the Nurse Practitioner®, AANP represents the interests of NPs as providers of high-quality, cost-effective, comprehensive, patient-centered health care. To locate an NP in your community, visit npfinder.com. For more information about NPs, visit aanp.org.

SOURCE American Association of Nurse Practitioners


These press releases may also interest you

at 04:20
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the data from a successful Phase Ib/IIa trial for lead candidate EXN407. These data...

at 04:05
Dr Antoine Amer, supported by Otium Capital, announced the creation of Enosium Life Science, a group poised to redefine services in the healthcare market by acquiring and combining best-in-class life science experts in Europe. Enosium Life Science...

at 04:00
Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today that it has received Fast Track designation from the U.S. Food...

at 03:30
Fibrocor Therapeutics Inc. ('Fibrocor' or 'the...

at 03:30
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce the opening of its new laboratory facilities on 7 March at its...

at 03:05
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, today announced successful completion of...



News published on and distributed by: